Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Cytokeratin 14/17 Polyclonal Antibody
GREENER_CHOICE

Catalog No. PIPA568451
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIPA568451 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIPA568451 Supplier Invitrogen™ Supplier No. PA568451
Only null left
Add to Cart
Add to Cart

Rabbit Polyclonal Antibody

Predicted to react with Mouse and Rat samples.

Cytokeratins(CK) are intermediate filaments of epithelial cells, both in keratinizing tissue (ie. Skin) and non-keratinizing cells (ie. Mesothelial cells). Although not a traditional marker for endothelial cells, cytokeratins have also been found in some microvascular endothelial cells. Atleast 20 different CKs in the molecular range of 40-70 k Da and isoelectric points of 5-805 can be identified using two dimensional gel electrophoresis. Biochemically, most members of the CK family fall into one of two classes, type I (acidic polypeptides) and type II (basic polypeptides). At least one member of the acidic family and one member of the basic family is expressed in all epithelial cells. Monoclonal antibodies to cytokeratin proteins can be useful markers for tumor identification and classification. Belonging to the type A (acidic) subfamily of low molecular weight keratins and existing in combination with keratin 5, keratin 14 distinguishes stratified epithelial cells from simple epithelial cells and is useful in identification of squamous cell carcinomas. It is considered a prognostic marker in breast carcinomas.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Cytokeratin 14/17
Applications Immunohistochemistry (Paraffin), Western Blot
Classification Polyclonal
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.5% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4
Gene KRT14
Gene Accession No. P02533, Q04695, Q61781, Q6IFU8, Q6IFV1, Q9QWL7
Gene Alias 39.1; AI626930; CK14; CK-14; CK-17; cytokeratin 14; cytokeratin-14; Cytokeratin-17; EBS3; EBS4; epidermolysis bullosa simplex, Dowling-Meara, Koebner; K14; K17; Ka14; Ka17; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 17; keratin 17, type I; keratin complex 1, acidic, gene 14; keratin complex 1, acidic, gene 17; keratin, type I cytoskeletal 14; Keratin, type I cytoskeletal 17; keratin-14; Keratin-17; Krt-1.14; Krt1-14; Krt1-17; KRT14; KRT17; krt17 {ECO:0000250; LOC100737113; NFJ; PC; PC2; PCHC1; type I keratin Ka14; Type I keratin Ka17; UniProtKB:Q04695}
Gene Symbols KRT14, KRT17
Host Species Rabbit
Immunogen Synthesized peptide derived from human Cytokeratin 14/17 [aa 261-310].
Purification Method Antigen affinity chromatography
Quantity 100 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 16664, 16667, 287701, 287702, 3861, 3872
Target Species Human, Mouse, Rat
Content And Storage -20°C
Product Type Antibody
Form Liquid
Isotype IgG
Show More Show Less
WARNING: Cancer - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.